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In Brief
In this study, Um et al. identify leucine-
rich repeat transmembrane protein 3
(LRRTM3) as a crucial regulator of
excitatory synapse development in
dentate gyrus granule neurons. Two
different splice variants of LRRTM3
promote excitatory synapse
development, but a shorter variant of
LRRTM3 that can bind to PSD-95 controls
activity-dependent surface expression of
the AMPA-type glutamate receptor.
Further characterization of LRRTM3-
knockout animals revealed that LRRTM3
is required for excitatory synapse
structure and function in vivo. Lastly,presynaptic neurexins are required for the
LRRTM3 synaptogenic activity that
induces presynaptic differentiation,
suggesting that LRRTM3 performs
synapse-organizing functions that are
both redundant and non-redundant
relative to those of other LRRTM family
members.
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The four members of the LRRTM family (LRRTM1-4)
are postsynaptic adhesion molecules essential for
excitatory synapse development. They have also
been implicated in neuropsychiatric diseases. Here,
we focus on LRRTM3, showing that two distinct
LRRTM3 variants generated by alternative splicing
regulate LRRTM3 interaction with PSD-95, but not
its excitatory synapse-promoting activity. Overex-
pression of either LRRTM3 variant increased excit-
atory synapse density in dentate gyrus (DG) granule
neurons, whereas LRRTM3 knockdown decreased
it. LRRTM3 also controlled activity-regulated AMPA
receptor surface expression in an alternative
splicing-dependent manner. Furthermore, Lrrtm3-
knockoutmice displayed specific alterations in excit-
atory synapse density, excitatory synaptic transmis-
sion and excitability in DG granule neurons but not in
CA1 pyramidal neurons. Lastly, LRRTM3 required
only specific splice variants of presynaptic neurexins
for their synaptogenic activity. Collectively, our data
highlight alternative splicing and differential presyn-
aptic ligand utilization in the regulation of LRRTMs,
revealing key regulatory mechanisms for excitatory
synapse development.INTRODUCTION
Transsynaptic adhesion molecules are central synapse orga-
nizers that orchestrate synapse assembly, maturation, specifica-
tion, and plasticity (Ko et al., 2015a; Missler et al., 2012). Recent
research has identified a diverse array of synaptogenic adhesion
molecules and investigated their mechanisms of action in808 Cell Reports 14, 808–822, February 2, 2016 ª2016 The Authorsdifferent synaptogenesis contexts. Leucine-rich repeat (LRR)-
containing transmembrane proteins (LRRTMs), in particular,
have emerged as being important for excitatory and inhibitory
synapse development. Notably, LRRTMs as well as NGLs
(netrin-G ligands), SALMs (synaptic adhesion-like molecules),
Slitrks (Slit and Trk-like family), and FLRTs (fibronectin LRR
transmembrane protein) were shown to be crucial for various as-
pects of synapse development (de Wit and Ghosh, 2014; Ko,
2012; Missler et al., 2012; S€udhof, 2008; Takahashi and Craig,
2013; Um and Ko, 2013).
The LRRTM family is composed of four members, LRRTM1 to
LRRTM4, which are only found in vertebrates (Laure´n et al.,
2003). They share similar domain architectures consisting of
ten LRR domains and a single transmembrane segment but a
distinct cytoplasmic stretch that ends with a type I PDZ-binding
motif that mediates binding to the excitatory postsynaptic scaf-
folding protein PSD-95 (Laure´n et al., 2003; Linhoff et al., 2009;
Siddiqui et al., 2013; Soler-Llavina et al., 2013). All four LRRTMs
are able to induce presynaptic differentiation in heterologous
synapse-formation assays (de Wit et al., 2009; Ko et al., 2009;
Linhoff et al., 2009; Siddiqui et al., 2010), although LRRTM3 dis-
plays lower synaptogenic activity relative to other LRRTM family
members (de Wit et al., 2009; Linhoff et al., 2009).
Postsynaptic LRRTMs require distinct sets of presynaptic li-
gands to instruct presynaptic assembly. For example, LRRTM1
and LRRTM2 bind to a subset of presynaptic neurexin splice var-
iants (Ko et al., 2009; Siddiqui et al., 2010), whereas LRRTM4
forms complexes with heparan sulfate proteoglycans and pro-
tein tyrosine phosphatase s (HSPGs/PTPs) (de Wit and Ghosh,
2014; de Wit et al., 2013; Ko et al., 2015b; Siddiqui et al.,
2013). Accordingly, knockdown (KD) of presynaptic neurexins
in cultured neurons completely abolishes the synaptogenic ac-
tivity of LRRTM2, and KD of presynaptic PTPs significantly de-
creases the activity of LRRTM4 (Gokce and S€udhof, 2013;
Ko et al., 2015b). Members of the LRRTM family also exhibit
discrete region-specific expression patterns in the hippocampus
and cerebellum. In the hippocampus, LRRTM1 and LRRTM2
proteins are strongly expressed in the CA1 region, whereas
LRRTM3 and LRRTM4 proteins are prominently expressed in
the dentate gyrus (DG) (Laure´n et al., 2003; Linhoff et al., 2009;
Siddiqui et al., 2013).
A subset of LRRTMs is involved in AMPA (a-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid) receptor trafficking and
function. For example, double KD of LRRTM1 and LRRTM2 in
the CA1 hippocampal region of newborn mice reduces AMPA-
receptor-mediated excitatory synaptic currents and blocks
maintenance of long-term synaptic potentiation (LTP) (Soler-Lla-
vina et al., 2011, 2013). Intriguingly, neurexin binding by LRRTM2
is responsible for LTP maintenance and surface delivery of
AMPA receptors during chemical LTP (cLTP) (Soler-Llavina
et al., 2013). In a similar vein, presynaptic neurexin-3 controls
AMPA receptor surface expression and N-methyl-D-aspartate
(NMDA)-receptor-dependent LTP in an alternative-splicing-
dependent manner, partly via interactions with LRRTM2 (Aoto
et al., 2013). Furthermore, LRRTM4 forms physical complexes
with the GluA2 subunit of AMPA receptors and is required for
cLTP-induced synaptic surface trafficking of GluA1 subunits
(Schwenk et al., 2012; Shanks et al., 2012; Siddiqui et al., 2013).
Analyses of in vivo LRRTM functions in knockout (KO) mice
have revealed subtle anatomical and significant functional and
behavioral defects. Lrrtm1-KO mice display increased VGLUT1
(vesicular glutamate transporter 1) immunofluorescence, altered
distribution of synaptic vesicles, and altered hippocampal syn-
apse morphology and density (Linhoff et al., 2009; Takashima
et al., 2011). These mice also show impaired cognitive functions,
resulting in schizophrenia-like and claustrophobia-like behaviors
(Takashima et al., 2011; Voikar et al., 2013). Lrrtm4-KOmice also
exhibit impaired excitatory synaptic transmission and reduced
excitatory synapse density in DG granule neurons, but not in
CA1 pyramidal neurons (Siddiqui et al., 2013). Not surprisingly,
all four LRRTMs are associated with various neuropsychiatric
disorders (de Wit and Ghosh, 2014).
Here, we focus on LRRTM3 to address a subset of key
questions left unanswered by prior studies. We found that
two different LRRTM3 variants produced by alternative
splicing, L3S and L3L, differ with respect to PSD-95 binding,
although they exhibit comparable synapse-boosting effects
when presented in heterologous synapse-formation assays
or overexpressed in cultured hippocampal DG neurons. How-
ever, we found that L3S, but not L3L, is required for activity-
induced AMPA receptor surface expression in DG neurons.
Using Lrrtm3-KO mice, we also showed that loss of LRRTM3
led to marked reductions in excitatory synapse density and
spontaneous synaptic transmission and excitability in DG
granule neurons, but not in CA1 pyramidal neurons. Further-
more, LRRTM3 bound to both glypican-4 (GPC-4) and neurex-
ins in vitro but required only the latter to induce presynaptic
differentiation in heterologous synapse-formation assays
via distinct alternative splicing-dependent mechanisms. Taken
together, these data suggest that LRRTM3 maintains DG
excitatory synapse development through both distinct molec-
ular mechanisms and mechanisms shared with other LRRTM
family members and that presynaptic neurexins are function-
ally common ligands for the LRRTM family of synaptic adhe-
sion molecules.CRESULTS
Alternative Splicing Produces LRRTM3 Variants with
Both Distinct and Shared Biochemical and Cellular
Properties
All LRRTMs have been shown to contain a C terminus that binds
to type I PDZ proteins (Laure´n et al., 2003; Linhoff et al., 2009),
but alternative splicing of Lrrtm3 and Lrrtm4 mRNA also pro-
duces longer protein variants, LRRTM3L (L3L) and LRRTM4L
(L4L), with a unique, presumably non-PDZ-binding C terminus
(Figures 1A and S1). The corresponding sequences, encoded
by the alternatively spliced 30-most exon (exon-3), are evolution-
arily conserved, suggesting the importance of the intracellular
region of these LRRTM variants (Figures 1A and S1). Semiquan-
titative and qRT-PCR analyses indicated that at postnatal day 14
(P14) in the mouse, Lrrtm3S mRNA is expressed almost exclu-
sively in the cerebellum, whereas Lrrtm3L shows expression in
several brain areas (Figure 1B). In the adult brain, expression of
Lrrtm3S becomes more widespread, but it is still highest in the
cerebellum. The two Lrrtm4 splice variants show a similar, wide-
spread pattern of expression in several CNS areas at P14, with
strongest expression in the cerebral cortex, hippocampus, and
olfactory bulb. In the adult brain, the expression pattern is
similar, but the level of Lrrtm4L expression is reduced (Figure 1B).
These RT-PCR results are in general agreement with the pattern
of Lrrtm3 and Lrrtm4 expression reported in a previous in situ hy-
bridization study of adult mouse brain using a probe that de-
tected both mRNA variants (Laure´n et al., 2003).
LRRTM1, LRRTM2, and LRRTM4 are localized to the PSD of
excitatory synapses (de Wit et al., 2009, 2013; Linhoff et al.,
2009; Siddiqui et al., 2013), but the distribution of LRRTM3 has
not been investigated. For this purpose, we sought to generate
polyclonal antibodies against various immunogenic sequences
in either L3L or L3S (data not shown) and were able to success-
fully develop an antibody against a C-terminal sequence of L3L
(Figure S2A). This antibody (JK092) was specific for L3L (did
not cross-react with L3S) and produced a single immunoreactive
band of75 kDa in western blots of the synaptosomal fraction of
adult rat brains (Figure S2B). The expression of L3L gradually
increased during postnatal brain development (Figure S2C).
Moreover, L3L proteins were detected in various subcellular
fractions, including crude synaptosomes (P2) and synaptic
membranes (LP1) (Figure S2D). Notably, L3L was enriched in
detergent-resistant PSD fractions (Figure S2E). These data indi-
cate that LRRTM3 (at least L3L) is associated with excitatory
synaptic membranes. In accord with biochemical data, confocal
microscopy revealed that L3L immunoreactivity was closely
associated with the excitatory marker proteins VGLUT1 and
PSD-95, but not with the inhibitory marker proteins GAD67 and
gephyrin in cultured hippocampal neurons (Figures S2F–S2J).
L3L immunoreactivity was also prominent outside VGLUT1- or
PSD-95-positive excitatory synaptic sites, consistent with its
widespread distribution in various subcellular fractions (see Fig-
ure S2D). To corroborate these observations, we expressed
monomeric Venus (mVenus) fluorescent protein fused to L3L
(L3L-mVenus) in cultured hippocampal neurons and immuno-
stained them for VGLUT1 and PSD-95 (Figure S2K). mVenus
immunofluorescence in L3L-mVenus-expressing neurons wasell Reports 14, 808–822, February 2, 2016 ª2016 The Authors 809
clustered at excitatory synapse sites (55% ± 5% and 49% ± 6%
of L3L-mVenus-positive puncta matches with PSD-95 and
VGLUT1, respectively), suggesting that endogenous L3L pro-
teins, similar to L3S, localize to excitatory synapses (Minatohara
et al., 2015).
Next, we performed in situ hybridization analyses of mouse
brains in various developmental stages using individual iso-
form-specific probes (Figure 1C). We found that both long and
short isoforms of LRRTM3 and LRRTM4 showed widespread
expression, including the DG region of the hippocampus, cere-
bellum, cerebral cortex, and olfactory bulb (Figure 1C). Notably,
we found that both Lrrtm3L and Lrrtm3S mRNAs are expressed
in the DG of the hippocampus of adult mouse brains, although
they showed distinct expression patterns throughout mouse
brain development (Figure 1C). In contrast, the distribution pat-
terns of Lrrtm4S and Lrrtm4L mRNAs were similar and were
not significantly changed in developing and adult brains (Fig-
ure 1C). As expected, we confirmed that L3S and L4S, but not
L3L or L4L, interacted with PSD-95, as determined by coimmu-
noprecipitation assays in HEK293T cells and coclustering as-
says in COS-7 cells (Figures 1D and 1E). Collectively, these
data indicate that distribution patterns in developing and adult
mouse brains and PSD-95-binding properties of alternative
splice variants of LRRTM3 are distinct but share the same excit-
atory synapse localization.
Overexpression of LRRTM3 Increases Excitatory
Synapse Numbers in DG Granule Neurons
LRRTM3 was previously reported to exhibit the lowest synapto-
genic activity among the four LRRTMs in heterologous syn-
apse-formation assays (de Wit et al., 2009; Linhoff et al., 2009).
However, we found that the newly engineered L3S and L3L con-
structs displayed a strong ability comparable to that of LRRTM2
(L2) and LRRTM4 (L4S and L4L) to trigger presynaptic differenti-
ation in cultured hippocampal neurons, suggesting that LRRTM3
also possesses potent synaptogenic activity (Figures 1F and 1G).
Next, we examined whether LRRTM3 exhibits synapse-pro-
moting activities by transfecting hippocampal neurons at
10 days in vitro (DIV10) with mVenus-fused L3L or L3S and im-
munostaining them at DIV14 for excitatory synaptic markers
(VGLUT1 and Shank) and for inhibitory synaptic markers
(GAD67 and gephyrin) (Figures 1H, 1I, and S3). Because Lrrtm3
mRNAs are specifically expressed in the DG and not in other
subfields of the hippocampus (Figure 1C; Laure´n et al., 2003),
we classified the transfected neurons based on their immunore-
activity for Prox1, a DG granule neuron-specific marker, and
CTIP2, a CA1/DG neuron marker, and analyzed them separately
(Figures 1H, 1I, and S3). We found that both L3S and L3L ex-
hibited excitatory, but not inhibitory, synapse-promoting activ-
ities in cultured hippocampal DG neurons (Figures 1H and 1I).
The synapse-promoting activity of L3S and L3L were restricted
to Prox1-positive DG neurons (Figures 1H, 1I, and S3). In addi-
tion, overexpression of L3L increased excitatory postsynapse
specialization (labeled by Shank), but not inhibitory postsynapse
specialization (labeled by gephyrin) (Figure S3). Taken together,
these results suggest that both LRRTM3 splice variants are syn-
aptogenic, inducing presynaptic differentiation and increasing
excitatory synapse number.810 Cell Reports 14, 808–822, February 2, 2016 ª2016 The AuthorsLRRTM3 Knockdown Reduces Excitatory Synapse
Numbers in DG Granule Neurons
To examine whether endogenous LRRTM3 is required for excit-
atory synapse development in DG granule neurons, we first de-
signed small hairpin RNAs (shRNAs) that targeted Lrrtm3 or
Lrrtm4mRNA (Figures S4A and S4B). To test their effectiveness,
we expressed shRNAs in cultured mouse cortical neurons using
lentiviruses and quantified endogenous target mRNA levels by
qRT-PCR (Figure S4B). These experiments identified shRNAs
that suppressed expression of endogenous mRNAs for Lrrtm3
(J16) and Lrrtm4 (J30) by 80% and 90%, respectively (Fig-
ure S4B). We then investigated whether single KD of LRRTM3
or LRRTM4 altered synapse numbers in cultured DG neurons
(Figure 2). To accomplish this, we transfected cultured DG neu-
rons at DIV8 with vectors that express only EGFP (control) or co-
express EGFP with shRNAs against Lrrtm3 (L3 KD) or Lrrtm4 (L4
KD). We then immunostained the transfected neurons for
VGLUT1 or GAD67 at DIV14 and quantified the density of excit-
atory and inhibitory synapses on dendrites of the transfected
neurons (Figures 2A–2D). We found that the synapse loss
induced by L3 or L4 KD was specific for excitatory synapses
and not for inhibitory synapses (Figures 2A–2D). Strikingly, dou-
ble KD of LRRTM3 and LRRTM4 (L3/L4 DKD) did not further
decrease the excitatory synapse numbers than KD of either pro-
tein alone, suggesting that both LRRTM3 and LRRTM4 may
share common pathways in maintenance of excitatory synapse
structure at DG neurons (Figures 2A–2D). More importantly, co-
expression of an shRNA-resistant form of L3S or L3L (i.e., rescue
vectors) completely eliminated the deficits in excitatory synapse
density observed with L3 KD (Figures 2A–2D), confirming that
the observed phenotypes are not attributable to off-target ef-
fects. Collectively, these data complement the results obtained
with gain-of-function experiments (described above).
LRRTM3 Controls Synaptic-Activity-Induced
AMPA Receptor Surface Expression in an
Alternative-Splicing-Dependent Manner
It was previously reported that LRRTM2 and LRRTM4 associate
with AMPA receptors (Aoto et al., 2013; de Wit et al., 2009;
Schwenk et al., 2012; Siddiqui et al., 2013; Soler-Llavina
et al., 2013). Specifically, LRRTM2 was shown to directly
interact with the GluA1 subunit of AMPA receptors, and both
LRRTM2 and LRRTM4 were found to promote synaptic NMDA
receptor activity-dependent stabilization of the AMPA receptor
population, contributing to the regulation of extrasynaptic sur-
face AMPA receptor trafficking or endocytosis (Siddiqui et al.,
2013; Soler-Llavina et al., 2013). To determine whether LRRTM3
is also involved in similar cell-biological events in DG neurons,
we transfected cultured DG neurons at DIV8 with vectors that
express EGFP (control) or sh-LRRTM3 (L3 KD) or coexpress
L3 KD and shRNA-resistant LRRTM isoforms (+L3S rescue
or +L3L rescue). At DIV14, these neurons were stimulated
with cLTP solution (or control solution) for 5 min. Neurons
were then fixed and immunostained for surface expression of
the GluA1 subunit of AMPA receptors and imaged by confocal
microscopy (Figures 3A and 3B). We found that LRRTM3 KD
led to a significant reduction in surface AMPA receptors
following cLTP (Figures 3A and 3B). Strikingly, this phenotype
(legend on next page)
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was completely reversed by the simultaneous expression of
L3S wild-type (WT), but not L3L or the L3S point mutant (L3S
VA, an L3S that does not bind PSD-95) (Figures 3A and 3B).
These observations were also recapitulated using neurons
from Lrrtm3-KO mice (Figures 3C and 3D; see below). Thus,
LRRTM3, similar to LRRTM2 and LRRTM4, is required to main-
tain a subpopulation of AMPA receptors that is responsive to
cLTP stimulation. At this point, it is not apparent why the
LRRTM3 splice variants show differential behaviors in terms of
activity-regulated synaptic insertion of AMPA receptors, but a
plausible scenario would be that L3S controls activity-depen-
dent AMPA receptor trafficking through the PSD-95/TARP com-
plex, which is not available for L3L.
Lrrtm3-KO Mice Exhibit Morphological Defects in
Excitatory Synapse Development in DG Granule
Neurons
To investigate whether LRRTM3 is required for synapse struc-
ture and function in vivo, we utilized Lrrtm3-KO mice (Laakso
et al., 2012) (see Figures S4C and S4D). We first confirmed
that LRRTM3 mRNA transcripts are not detectable by in situ hy-
bridization analyses (Figure 4A). Western blot analyses using an
L3L-specific antibody further showed that LRRTM3 protein
expression was also completely abolished in these mice (Fig-
ure S4D; data not shown). We performed Nissl staining to
show the normal gross morphology of Lrrtm3-KO brains (Fig-
ure 4B). Expressions of other synaptic proteins were not quanti-Figure 1. Expression Patterns of Alternative Splice Variants of LRRTM
action with PSD-95, but Not Synapse-Promoting Activities
(A) Structures of mouse Lrrtm3 and Lrrtm4 genes, consisting of three coding exon
alternative splicing and polyadenylation. Exons are shown as boxes. Coding an
indicated by an angled line. The sizes of long introns are shown in parenthesis.
by white and black arrowheads, respectively. The transcripts correspond to
ENSMUST00000105439 (Lrrtm3L), ENSMUST00000136421 (Lrrtm4S), and ENSM
transcripts is predicted.
(B) Semiquantitative analysis of Lrrtm3 and Lrrtm4 expression by RT-PCR in P14
(L3S), Lrrtm3L (L3L), Lrrtm4S (L4S), Lrrtm4L (L4L) and controlGapdhmRNAs in dif
histograms of qRT-PCR (bottom) show Lrrtm3 and Lrrtm4mRNA expression in dif
stem; Cb, cerebellum; Ctx, cortex; Hpc, hippocampus; Ob, olfactory bulb; Sc, s
(C) Expression of Lrrtm3 and Lrrtm4mRNAs in developing and adult mouse brain
mouse brains were probed with L3L-, L3S-, L4L, and L4S-specific cRNAs. Cb, cer
bar represents 5 mm (applies to all images).
(D) Coimmunoprecipitation experiment demonstrating that L3S and L4S, but not
together with hemagglutinin (HA)-tagged LRRTMs, as indicated, into HEK293T
immunoblotting. A representative immunoblot, visualized using enhanced chemi
(E) Coclustering experiment performed in COS-7 cells demonstrating that L3S an
with HA-tagged LRRTMs (red), alone or together with EGFP-PSD-95 (green), and
antibodies.
(F and G) Representative images of heterologous synapse-formation assays (F) an
HEK293T cells expressing EGFP alone (control), HA-tagged LRRTM2 (L2), HA-tag
or HA-tagged LRRTM4S (L4S). Cocultured neurons were immunostained with an
erologous synapse-formation activity of LRRTMs, quantified as the ratio of synap
violet. Data shown are means ± SEMs; statistical significance was assessed by co
number of HEK293T cells analyzed as follows: Control, n = 15; HA-L3S, n = 12; H
represents 25 mm (applies to all images).
(H and I) Representative images (H) of Prox1-positive cultured hippocampal DG n
fusion protein (L3S-mVenus), or an LRRTM3L mVenus-fusion protein (L3L-mVe
antibodies to EGFP (blue) and VGLUT1 (excitatory presynaptic marker) or GAD67
images). Effects of LRRTM3 on synapse density were quantified (I). All data sho
comparing the various conditions to controls using Student’s t test (3*p < 0.001;
L3S/VGLUT1, n = 18; L3L/VGLUT1, n = 13; Cont./GAD67, n = 12; and L3S/GAD
812 Cell Reports 14, 808–822, February 2, 2016 ª2016 The Authorstatively altered at either P14 or P42 in Lrrtm3-KO brains
compared with WT brains (Figures 4C, 4D, and S4E).
A quantitative immunofluorescence analysis revealed a signif-
icant decrease in the intensity of VGLUT1 puncta in DG molecu-
lar layers (MML), but not in the CA1 stratum oriens (oriens), a
phenotype similar to that observed in Lrrtm4-KO mice (Figures
4E and 4F; Siddiqui et al., 2013). In contrast, the intensity of
GAD67 puncta was unchanged in both DGMML and CA1 oriens
(Figures 4E and 4F). We next analyzed dendritic spine density in
Golgi-stained brain sections. Spine density on dendrites in DG
granule neurons was also significantly reduced in Lrrtm3-KO
mice compared with WT littermates (Figures S4F and S4G).
Moreover, electron microscopy analyses showed that the
number of dendritic spines (i.e., asymmetric/excitatory synap-
ses) in the DG middle molecular layer (MLL) was modestly, but
significantly, decreased at P14 (20%) and P42 (15%) in
Lrrtm3-KO mice (Figures 5A–5C, S5A, and S5B). This reduction
in excitatory synapse density at the ultrastructural level was not
observed in the CA1 pyramidal neurons of Lrrtm3-KO mice (Fig-
ures 5A–5C). In contrast, the number of GABA-positive presyn-
aptic boutons (i.e., symmetric/inhibitory synapse) in the DG
was not reduced in Lrrtm3-KO mice (Figures 5D–5F). The thick-
ness and length of excitatory PSD- or GABA-positive boutons
were unchanged by ablation of LRRTM3 protein (Figures 5D–
5F). Collectively, these results demonstrate that the loss of
LRRTM3 protein decreases the number of excitatory synapses
in vivo without altering their gross ultrastructure.3 and LRRTM4 and Alternative Splicing in LRRTM3 Regulates Inter-
s (e1–e3), and transcripts encoding the long and short isoforms, resulting from
d non-coding exonic regions are in gray and white, respectively. Splicing is
The primers used for quantitative and semiquantitative RT-PCR are marked
the following ENSEMBL IDs with the highest Transcript Support Level:
UST0000147663 (Lrrtm4L). The length of the 30 UTR in Lrrtm3S (and in Lrrtm4L)
and adult mice. Representative gel images (top) show expression of Lrrtm3S
ferent brain regions and kidney from three independent experiments. Summary
ferent brain regions of P14 and adult mice (n = 4mice for each tissue). Bs, brain
pinal cord; and W, water.
s. Sections from embryonic day 18 (E18), P7, P14, P21, and adult (6-week-old)
ebellum; Ctx, cerebral cortex; Hc, hippocampus; and OB, olfactory bulb. Scale
L3L or L4L, interact with PSD-95. Untagged PSD-95 was transfected alone or
cells, and coimmunoprecipitation of PSD-95 with LRRTMs was assayed by
luminescence, is shown.
d L4S, but not L3L or L4L, interact with PSD-95. COS-7 cells were transfected
visualized by double immunofluorescence staining with anti-EGFP and anti-HA
d summary graphs (G). Hippocampal neurons were cocultured for 2 days with
ged LRRTM3L (L3L), HA-tagged LRRTM3S (L3S), HA-tagged LRRTM4L (L4L),
tibodies to EGFP/HA (blue) and the presynaptic marker synapsin I (red). Het-
sin staining to HA fluorescence. Coincident blue and red signals are shown in
mparing the various conditions to controls using Student’s t test (n denotes the
A-L3L, n = 14; HA-L4S, n = 16; HA-L4L, n = 18; and HA-L2, n = 12). Scale bar
eurons transfected at DIV10 with EGFP alone (Control), an LRRTM3S mVenus-
nus). Cultures were analyzed at DIV14 by double immunofluorescence with
(inhibitory presynaptic marker; red). Scale bar represents 5 mm (applies to all
wn in (G) and (I) are means ± SEMs; statistical significance was assessed by
n denotes the number of neurons analyzed as follows: Cont./VGLUT1, n = 12;
67, n = 13).
Figure 2. Knockdown of LRRTM3 Reduces Excitatory Synapse Numbers in DG Granule Neurons
(A) Representative images of cultured hippocampal DG neurons transfected at DIV8with a lentiviral vector expressing EGFP alone (Control), LRRTM3 knockdown
(L3 KD; with/without L3S or L3L rescue vectors), LRRTM4 KD (L4 KD) or LRRTM3/4 double KD (L3/L4 DKD), and analyzed by double immunofluorescence with
antibodies to EGFP (green) and VGLUT1 or GAD67 (red) at DIV14. Scale bar represents 5 mm (applies to all images).
(B–D) Summary graphs of the effects of single or double KD of LRRTM3 and/or LRRTM4 on marker puncta density (B); quantified using VGLUT1 or GAD67
immunoreactivity), puncta size (C) and puncta intensity (D), and phenotypic restoration by LRRTM3S (L3S rescue), but not by LRRTM3L (L3L rescue). L3 and L4
denote LRRTM3 and LRRTM4. Data shown are means ± SEMs from three independent culture experiments; statistical significance was assessed by comparing
the various conditions to controls using ANOVA with Tukey’s test (*p < 0.05 and 2*p < 0.01; n denotes the number of neurons analyzed as follows: Control/
VGLUT1, n = 12; L3 KD/VGLUT1, n = 12; L4 KD/VGLUT1, n = 12; L3/L4 DKD/VGLUT1, n = 12; L3S rescue/VGLUT1, n = 14; L3L rescue/VGLUT1, n = 12; Control/
GAD67, n = 13; L3 KD/GAD67, n = 12; L4 KD/GAD67, n = 12; and L3/L4 DKD/GAD67, n = 12).Excitatory Synaptic Transmission Is Specifically
Impaired in DG Granule Neurons of Lrrtm3-KO Mice
To determine whether excitatory synaptic function is changed as
a result of genetic perturbation of LRRTM3, we performed
whole-cell recordings from DG granule cells in hippocampal
slices from WT and Lrrtm3-KO mice (Figure 6). We found that
the amplitude of miniature excitatory postsynaptic currents
(mEPSCs) was markedly reduced in LRRTM3-deficient neurons
(Figures 6A–6C). The amplitude of spontaneous excitatory
events (sEPSCs) was reduced to the same extent in Lrrtm3-KO
neurons (Figures 6D and 6E). Strikingly, the frequency of
mEPSCs was significantly increased in neurons from Lrrtm3-
KO mice compared with those from WT mice, whereas the fre-
quency of sEPSCs was not altered (Figures 6A–6E). No changes
were observed in the frequency or amplitude of miniature inhib-
itory postsynaptic currents (mIPSCs) (Figures 6D and 6F).CNext, to examine whether the intrinsic excitability of DG
granule neurons is affected by LRRTM3 loss, we determined
the firing rate of DG granule neurons from Lrrtm3-KO mice using
the current-clamp configuration of the patch-clamp technique
(Figures 6G and 6H). DG granule cells were injected with 500-
ms current steps, ranging from 50 to 250 pA in 50-pA incre-
ments. The firing rate of DG granule neurons in LRRTM3-KO sli-
ces was lower than that of neurons in WT slices (Figures 6G and
6H). In contrast, recordings from CA1 pyramidal neurons re-
vealed no differences in the firing rates of WT and Lrrtm3-KO
neurons (Figures 6G and 6H) and no changes in intrinsic mem-
brane properties (Table S2). These results indicate that the def-
icits in excitatory synaptic transmission observed in LRRTM3-
KO neurons are accompanied by reduced excitability in DG
granule cells. We also found that Lrrtm3 ablation decreased
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Figure 3. LRRTM3 Controls cLTP-induced Surface AMPA Receptor Expression in DGGranule Neurons in an Alternative Splicing-Dependent
Manner
(A) Representative images of cultured hippocampal DG neurons transfected at DIV8 with a lentiviral vector expressing EGFP alone (Control) or LRRTM3 KD
(L3 KD; with/without L3S or L3L rescue vectors), and analyzed by triple immunofluorescence with antibodies to Prox1 (not shown), EGFP (blue), and AMPA
receptor subunit GluA1 (red) 20min after treatment with control (Control) or glycine-containing solution (+ cLTP) at DIV14. Scale bar represents 5 mm (applies to all
images).
(B) Summary graphs showing surface GluA1 puncta intensity in various experimental culture sets, as indicated. Data shown are means ± SEMs from three in-
dependent culture experiments; statistical significance was assessed by comparing the various conditions to controls using ANOVAwith Tukey’s test (**p < 0.01;
n denotes the number of neurons analyzed as follows: Control/Control, n = 14; Control/L3 KD, n = 14; Control/L3 KD (+L3S WT rescue), n = 14; Control/L3 KD
(+L3S VA rescue), n = 14; Control/L3 KD (+L3L rescue), n = 14; cLTP /Control, n = 14; cLTP /L3 KD, n = 14; cLTP /L3 KD (+L3S WT rescue), n = 14; cLTP/L3 KD
(+L3S VA rescue), n = 14; and cLTP/L3 KD (+L3L rescue), n = 14).
(C) A chemical LTP (cLTP) containing glycine led to a selective increase in surface GluA1 in WT, but not LRRTM3-KO, DG granule neurons identified by Prox1
immunoreactivity. Scale bar represents 5 mm (applies to all images).
(D) Quantification of integrated intensity of surface GluA1 normalized to control condition. All data are expressed as means ± SEMs; statistical significance
was assessed in comparison to controls using Student’s t test (***p < 0.001; n denotes the number of neurons analyzed as follows: Control/WT, n = 14; cLTP/WT,
n = 14; Control/KO, n = 14; and cLTP/KO, n = 14).release probability, at an interstimulus interval of 20 ms (Figures
6I and 6J). In addition, input-output curves of excitatory synaptic
transmission at perforant pathway (PP) to DG granule neurons,
measured by patch-clamp recordings, revealed a small
decrease in evoked excitatory synaptic transmission in Lrrtm3-
KO mice compared with WT mice, but the maximal response
was comparable (Figures S6A and S6B). Furthermore, a 20-Hz
stimulus led to much faster depression of evoked EPSC ampli-
tude in Lrrtm3-KO mice (Figures S6C and S6D). These results
suggest that loss of LRRTM3 results in increased neurotrans-814 Cell Reports 14, 808–822, February 2, 2016 ª2016 The Authorsmitter release, leading to a slower recovery of the releasable
vesicle pool. Finally, we examined whether long-term synaptic
plasticity is altered in Lrrtm3-KO mice (Figure S6E). Long-term
potentiation (LTP) was induced via high-frequency stimulation
(HFS) of PP-to-DG synapses. Our data showed that deletion of
LRRTM3 tends to decrease LTP by 15% in PP-to-DG synapses
(but did not reach a statistically significant decrease in LTP) (Fig-
ure S6E). Collectively, our electrophysiology data demonstrate
that LRRTM3 is postsynaptically required for excitatory synaptic
transmission in DG granule neurons.
Figure 4. Excitatory Synapse Development
is Impaired in the DG of Lrrtm3-KO Mice
(A) Validation of the lack of Lrrtm3mRNAs in adult
(P42) WT or Lrrtm3-KO brains by in situ hybridi-
zation. Three different cRNAs were used: L3S to
detect LRRTM3S, but not LRRTM3L; and L3L to
detect LRRTM3L, but not LRRTM3S. Scale bar
represents 5 mm (applies to all images).
(B) Normal gross morphology of the Lrrtm3-KO
brain at P35. Hippocampal DG morphology is
highlighted for comparison to normal DG layered
structures of the age-matchedWT brain. Scale bar
represents 500 mm (applies to all images).
(C and D) Representative immunoblots (C) and
summary graphs of synaptic protein levels (D) in
crude synaptosomal fractions of P14 and P42 WT
and Lrrtm3-KO brains (3-5 pairs) analyzed by
semiquantitative immunoblotting. Hippocampal
fractions (HP) from P42 WT and Lrrtm3-KO mice
were further dissected and analyzed in parallel.
Statistical significance was assessed using
ANOVA with Tukey’s test. For additional immu-
noblot images, see Figure S4E.
(E) Confocal images revealed a reduction in
VGLUT1 puncta intensity in the DGmolecular layer
of Lrrtm3-KO mice at P42 compared with age-
matched WT mice but not in the CA1 stratum ori-
ens. No difference was observed in GAD67 puncta
intensity. Scale bar represents 10 mm (applies to all
images).
(F) Quantification of VGLUT1 and GAD67
puncta intensity per tissue area. Data shown
are means ± SEMs from three independent culture
experiments; statistical significance was as-
sessed by comparing the various conditions to
controls using ANOVAwith Tukey’s test (*p < 0.05;
n = 3 mice for all conditions). For Golgi-COX
stained images, see Figures S4F and S4G.LRRTM3 Requires Specific Neurexin Splice Variants for
Presynaptic Differentiation
LRRTM3 regulates the maintenance of surface AMPA recep-
tors in a synaptic activity- and alternative-splicing-dependent
manner (Figure 3). However, it remains to be determined how
LRRTM3 performs its synapse-promoting functions. Specif-
ically, the extracellular ligands of LRRTM3 have not been clearly
defined, in part because LRRTM3 was previously reported toCell Reports 14, 808–822exert marginal synaptogenic activity (de
Wit et al., 2009; Linhoff et al., 2009).
Nonetheless, GPC-4 and/or neurexins
have been postulated as candidate li-
gands for LRRTM3 (de Wit et al., 2013;
Ko et al., 2009; but see Siddiqui et al.,
2013). We first performed cell surface-
binding assays using recombinant immu-
noglobulin (Ig)-fusion proteins of GPC-4
(Ig-GPC-4) and HEK293T cells express-
ing LRRTM3-mVenus (Figure S7A). We
found that LRRTM3 avidly bound to
GPC-4 (Figure S7A), similar to LRRTM4
(de Wit et al., 2013; Ko et al., 2015b).Pull-down assays with Ig-neurexin-1b fusion proteins lacking
an insert at splice site 4 (SS4) showed that LRRTM3 also inter-
acted with neurexin-1b, at least in vitro (Figure S7B; Ko et al.,
2009). To address previously unresolved issues surrounding
LRRTMs, we performed an extensive series of heterologous
synapse-formation assays (Figure 7). First, we asked whether
presynaptic neurexins or glypicans are required for the synapto-
genic activity of LRRTM3. In the case of glypicans, we generated, February 2, 2016 ª2016 The Authors 815
Figure 5. Lrrtm3-KO Mice Exhibit Decreased Excitatory Synapse Density in the DG, but Not the CA1 Region, of the Hippocampus
(A–C) Representative electron microscopy images (A) and summary graphs of excitatory synapse density (B) and PSD length and thickness (C) of the DG
molecular layer and CA1 stratum radiatum fromWT and Lrrtm3-KOmice (KO) at P42. Data shown aremeans ±SEMs (WTDG, n = 60 images, 392 synapses, 3male
littermates; KODG, n = 60 images, 347 synapses, 3males;WTCA1, n = 60 images, 472 synapses, 3male littermates; KOCA1, n = 60 images, 470 synapses, 3males).
White arrows indicate the PSD in dendritic spines of excitatory synapses, and arrowheads indicate perforated synapses. Statistical significance was assessed
using Student’s t test (*p < 0.05). Scale bar represents 500 nm (applies to all images).
(D–F) Representative electron microscopy images (D) and summary graphs of inhibitory synapse density (E) and GABA-positive terminal length and thickness (F)
of the DG molecular layer and CA1 stratum radiatum from WT and Lrrtm3-KO mice (KO) at P42. Data shown are means ± SEMs (WTDG, n = 60 images, 109
synapses, 3 male littermates; KODG, n = 60 images, 106 synapses, 3 males; WTCA1, n = 60 images, 108 synapses, 3 male littermates; KOCA1, n = 60 images, 104
synapses, 3 males). White arrows indicate synapse structure, asterisks indicate GABA-positive presynaptic terminals, and ‘‘d’’ denotes dendrites. Statistical
significance was assessed using Student’s t test. Scale bar represents 500 nm (applies to all images).
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Figure 6. Lrrtm3-KO Mice Display Impaired
Excitatory Synaptic Transmission in DG
Granule Neurons
(A–C) Representative traces (A) and summary
graphs (B) and (C) of mEPSCs recorded from DG
and CA1 regions of the hippocampus in WT (gray)
or Lrrtm3-KO mice (orange). Graphs show
means ± SEM (*p < 0.05 and 2*p < 0.01, Mann-
Whitney U test; n denotes the total number of
neurons analyzed as follows: mEPSCs/WTDG,
n = 14 cells/5 mice; mEPSCs/KODG, n = 14 cells/3
mice; mEPSCs/WTCA1, n = 15 cells/4 mice; and
mEPSCs/KOCA1, n = 17 cells/3 mice).
(D–F) Representative traces (D) and summary
graphs of sEPSCs (orange) (E) or mIPSCs (blue) (F)
recorded from DG and CA1 regions of hippo-
campus in WT (gray) and Lrrtm3-KO mice. Graphs
show means ± SEM (*p < 0.05, Mann-Whitney U
test; sEPSCs/WTDG, n = 12 cells/4 mice; sEPSCs/
KODG, n = 9 cells/2 mice; mIPSCs/WTDG, n = 17
cells/3 mice; and mIPSCs/KODG, n = 13 cells/2
mice).
(G and H) Representative traces (G) and summary
graphs (H) of intrinsic excitability measured as
firing rates in response to step depolarizing cur-
rents (duration 500 ms) in DG (top) and CA1 (bot-
tom) slices from WT (black) and Lrrtm3-KO mice
(orange). Individual points represent means ±
SEM (*p < 0.05 and 2*p < 0.01, Mann-Whitney U
test; WTDG, n = 16 cells/3 mice; KOCA1, n = 13
cells/3 mice; WTCA1, n = 18 cells/8 mice; and
KOCA1, n = 11 cells/5 mice).
(I and J) Representative traces (I) and summary
graphs (J) of paired-pulse ratios of AMPA recep-
tor-EPSCs recorded in the perforant pathway to
granule cell synapses (PP-DG) from WT (black)
and Lrrtm3-KO (orange) mice. Individual points
represent means ± SEM (*p < 0.05, Mann-Whitney
U test; WT, n = 15 cells/3 mice and KO, n = 18
cells/4 mice). Note that the paired-pulse ratio in
Lrrtm3-KO mice is significantly decreased at an
interstimulus interval of 20 ms.a lentiviral shRNA vector (sh-GPC-1/2/4) that knocks down
GPC-1, GPC-2, and GPC-4, all of which (among the six GPCs)
are strongly expressed in the hippocampus (Ko et al., 2015b).
In addition to this vector, we used previously characterized
lentiviral shRNAs against neurexins (sh-Nrx1/2/3) or PTPs (sh-
PTPs) (Ko et al., 2015b; Um et al., 2014b; Yim et al., 2013). Neu-
rexin triple KD (sh-Nrx1/2/3) drastically reduced the synapto-
genic activity of all LRRTMs examined, whereas GPC triple KD
(sh-GPC-1/2/4) significantly reduced the synaptogenic activity
of only LRRTM4 (Figures 7A and 7B). PTPs KD (sh-PTPs)
decreased only LRRTM4 activity, consistent with our previous
report that LRRTM4 activity is partially mediated by the
GPC-4/PTPs complex (Ko et al., 2015b).
The requirement of presynaptic neurexins for synaptogenic
activity was independently investigated in independent heterolo-Cgous synapse-formation assays using the LRRTM point mutants
(designated LRRTM2-EXAA, LRRTM3-EXAA, and LRRTM4-EXAA;
Figures 7C and S7C–S7E). The mutated LRRTM residues are all
conserved and predicted to abolish neurexin binding (Fig-
ure S7C; Siddiqui et al., 2010). Indeed, all LRRTM mutations
markedly decreased the synaptogenic activities of individual
LRRTMs (Figures 7C and S7D). Lastly, we tested whether a sub-
set of neurexin splice variants are required for LRRTM3 activity.
We found that Nrx1b-1 (Nrx1b variant lacking an insert at splice
site #SS4), but not Nrx1b-3 (Nrx1b variant containing an insert at
#SS4), reversed the deficit in the synapse-formation activity of
LRRTM3 observed in neurexin-deficient neurons (Figures 7D
and 7E). Intriguingly, both Nrx1b-1 and Nrx1b-3 were equally
capable of restoring the deficit in the synapse-formation activity
of LRRTM4, consistent with a previous report that LRRTM4ell Reports 14, 808–822, February 2, 2016 ª2016 The Authors 817
interacts with Nrx1b independent of its alternative splicing status
at #SS4 (Figures 7D and 7E; de Wit et al., 2013). Consistent with
this interpretation, both Ig-Nrx1b-1 and Ig-Nrx1b-3 pulled down
LRRTM4, whereas only Ig-Nrx1b-1 avidly bound to LRRTM3
(Figure S7B). Taken together, these data unequivocally reinforce
the conclusion that LRRTM3 primarily mediates its synaptogenic
activity through presynaptic neurexins in an alternative splicing-
dependent manner.DISCUSSION
In our current investigation of LRRTM3, we asked whether the
PSD-95-binding property of LRRTM3 has any physiological sig-
nificance and whether presynaptic neurexins are universally
required for LRRTM proteins. Most importantly, given the clinical
implications of LRRTM3 in autism spectrum disorders (ASDs)
and strong expression pattern in the DG—features shared with
LRRTM4—we asked how LRRTM3 contributes to specification
of excitatory synapse development, at least in the DG, with
the goal of shedding light on pathophysiological mechanisms
underlying the associated brain disorders. We report five key
observations:
1. Both Lrrtm3 and Lrrtm4 genes produce (by alternative
splicing) two protein variants with different (short or long)
C termini, of which only the short variants interact with
PSD-95. (Similar alternative splicing events do not exist
for Lrrtm1 or Lrrtm2.) This suggests that LRRTM3 and
LRRTM4 function may be controlled by as yet unknown
but likely region-specific spliceosomal machinery. The
expression of LRRTM3/4 splice variants that do not bind
to PSD-95 (i.e., L3L and L4L) is also developmentally regu-
lated and shows distribution patterns distinct from those
of PSD-95-interacting splice variants (Figures 1B and
1C). However, L3L, similar to L3S, is targeted to excitatory
synapse sites in cultured hippocampal neurons (Fig-
ure S2K). These data argue that PSD-95 interaction per
se does not orchestrate all the synaptic functions medi-
ated by synaptic adhesion molecules. Indeed, even in
the case of LRRTM2, excitatory synapse targeting does
not rely on PSD-95 interactions (Linhoff et al., 2009; Mina-
tohara et al., 2015); a similar independence of PSD-95
interaction has also been reported for neuroligin-1 (Dres-
bach et al., 2004). In contrast, netrin-G ligand-2 (NGL-2)
requires interaction with PSD-95 for its excitatory synapse
targeting (Kim et al., 2006).
2. Overexpression of either LRRTM3 splice variant increased
excitatory synapse numbers in DG granule neurons
(Figures 1H and 1I), similar to the actions of other
LRRTMs in facilitating excitatory synapse development.
Conversely, LRRTM3 KD induced a loss of excitatory syn-
apses in DG granule neurons (Figure 2). Re-expression
of either LRRTM3 splice variant completely reversed the
excitatory synapse reduction caused by LRRTM3 KD (Fig-
ure 2), suggesting that the intact extracellular sequences
of LRRTM3 are sufficient to promote excitatory synapse
development, a feature reminiscent of NL-1 and LRRTM2
(Ko et al., 2011). Notably, double KD of LRRTM3 and818 Cell Reports 14, 808–822, February 2, 2016 ª2016 The AuthorsLRRTM4 did not further decrease the excitatory synapse
loss beyond that induced by either LRRTM3 KD or
LRRTM4 KD, suggesting that these two proteins share
similar pathways in organizing excitatory synapse devel-
opment in DG granule neurons, an action dissimilar to
that of LRRTM1 and LRRTM2 at CA1 pyramidal neurons
(Ko et al., 2011; Soler-Llavina et al., 2011).
3. Most importantly, both LRRTM3 splice variants perform
distinct functions in activity-dependent surface expres-
sion of AMPA receptors in DG granule neurons (Figure 3).
LRRTM2 directly associates with AMPA receptor subunits
and is specifically required for maintenance of newly deliv-
ered AMPA receptors after cLTP induction; it also controls
AMPA receptor trafficking in concert with presynaptic
neurexin-3 (Aoto et al., 2013; Soler-Llavina et al., 2013).
Like LRRTM2, LRRTM4 forms physical complexes with
AMPA receptors and similarly acts to increase surface
GluA1 levels after cLTP (Schwenk et al., 2012; Siddiqui
et al., 2013). We demonstrated in the current study that
KO or KD of LRRTM3 abolishes surface expression of
the AMPA receptor GluA1 subunit after cLTP induction
(Figure 3), showing that LRRTM3 also contributes to the
maintenance of surface GluA1. Strikingly, re-expression
of the LRRTM3 L3S variant (which interacts with PSD-
95), but not L3L or L3S VA (which do not interact with
PSD-95), restored the deficit in activity-induced surface
GluA1 upregulation caused by LRRTM3 loss (Figure 3).
Consistent with this finding, deletion of LRRTM3 proteins
mildly decreased LTP in PP-to-DG synapses (Figure S6E).
These data suggest that LRRTM3 controls the activity-
dependent regulation of surface AMPA receptor trafficking
(i.e., exocytosis and/or endocytosis) through its PSD-95
interaction, possibly involving the PSD-95/TARP complex
(Nicoll et al., 2006), and further implies that other LRRTMs
may act similarly. It remains to be determinedwhether pre-
synaptic neurexins are also involved in LRRTM3-mediated
postsynaptic AMPA receptor trafficking, and which intra-
cellular alternative splicing machineries operate on
LRRTM3, as well as LRRTM4. One mechanism that might
plausibly control alternative splicing is specific synaptic
activity, reminiscent of situation with neurexin alternative
splicing (Aoto et al., 2013; Iijima et al., 2011).
4. Analyses with Lrrtm3-KO mice revealed that LRRTM3 is
specifically required for excitatory synapse structure and
function in DG granule neurons, but not in CA1 pyramidal
neurons, in vivo. Although gross synapsemorphology was
unchanged in Lrrtm3-KO brains, Golgi staining, electron
microscopy, and quantitative confocal microscopy re-
vealed that excitatory synapse numbers were reduced
(Figures 4 and 5). In accord with these structural defects
in Lrrtm3-KO brains, excitatory synaptic transmission
was also selectively impaired in DG granule neurons (Fig-
ure 6). The amplitude of sEPSCs and mEPSCs and excit-
ability were significantly reduced, whereas the frequency
of mEPSCs (but not that of sEPSCs) was unexpectedly
increased (Figures 6A–6E). In support of the increase in
mEPSC frequency in Lrrtm3-KO, the paired-pulse ratio
at a 20-ms interstimulus interval was decreased in
Figure 7. Presynaptic Neurexins Are Required for LRRTM3-mediated Presynaptic Differentiation
(A and B) The effect of triple neurexin knockdown (sh-Nrx1/2/3), triple GPC knockdown (sh-GPC-1/2/4), or single PTPs knockdown on the synaptogenic activities
of LRRTM3 (L3S), LRRTM4 (L4S), and LRRTM2 (L2). Representative images (A) of cocultures immunostained with antibodies tomVenus or HA (blue) and synapsin
(red). Coincident signals are indicated in violet. Scale bar represents 20 mm (applies to all images). Quantitation (B) of heterologous synapse-formation assays,
measured as the ratio of synapsin to EGFP/HA fluorescence signals. The dashed lines correspond to control values used as a baseline. Data shown are means ±
SEMs (3*p < 0.001 and *p < 0.05, ANOVA with Tukey’s test; n denotes the total number of HEK293T cells analyzed as follows: sh-Control/Control, n = 11; sh-
Control/L3S, n = 20; sh-Control/L4S, n = 12; sh-Control/L2, n = 11; sh-Nrx1/2/3/Control, n = 11; sh-Nrx1/2/3/L3S, n = 28; sh-Nrx1/2/3/L4S, n = 12; sh-Nrx1/2/3/
L2, n = 11; sh-GPC-1/2/4/Control, n = 10; sh-GPC-1/2/4/L3S, n = 10; sh-GPC-1/2/4/L4S, n = 11; sh-GPC-1/2/4/L2, n = 10; sh-PTPs/Control, n = 11; sh-PTPs/
L3S, n = 13; and sh-PTPs/L4S, n = 13).
(C) Summary graphs of heterologous synapse-formation assays examining the effects of point mutations on the synaptogenic activities of LRRTMs. Point
mutants of LRRTM2, LRRTM3, and LRRTM4 (LRRTM2-EXAA, LRRTM3-EXAA and LRRTM4-EXAA, respectively; EX, extracellular; AA, replaced with double al-
anines) exhibited significantly reduced synaptogenic activities compared to the corresponding WT protein. For representative images for experiments, see
Figure S7D. The dashed lines correspond to control values used as a baseline. Data shown are means ± SEMs (3*p < 0.001, Student’s t test; n denotes the total
number of HEK293T cells analyzed as follows: LRRTM2, n = 10; LRRTM2-EXAA, n = 11; LRRTM3, n = 10; LRRTM3-EXAA, n = 12; LRRTM4, n = 13; and LRRTM4-
EXAA, n = 12).
(D and E) Further analysis of the effects of triple neurexin knockdown (sh-Nrx1/2/3) on the synaptogenic activities of LRRTM3 (L3S) and LRRTM4 (L4S). HEK293T
cells expressing EGFP alone (Control), HA-L3S, or HA-L4S were cocultured with neurons infected with control lentiviruses (sh-Control) or lentiviruses expressing
sh-Nrx1/2/3, without or with coexpression of Nrx1b splice variants as indicated (+Nrx1b-1 or +Nrx1b-3). Representative images (D) and summary graphs (E)
for heterologous synapse-formation assays are presented. The dashed lines correspond to control values used as a baseline. Data shown are means ± SEMs
(legend continued on next page)
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Lrrtm3-KO mice (Figures 6I and 6J). Collectively, these
data suggest the operation of a possible compensatory
mechanism and further indicate that the tetrodotoxin
(TTX)-sensitive component of excitatory synaptic trans-
mission is markedly inactive whereas the TTX-resistant
component is hyperactive. Thus, the net effect of the
loss of LRRTM3 proteins is a reduction in sEPSCs. Alter-
natively, it is possible that a decreased network activity
in LRRTM3-deficient brains activates homeostasis mech-
anisms, increasing the mEPSC frequency. Regardless
of the precise mechanisms, our results unequivocally
demonstrated that all four LRRTMs are critical for excit-
atory synapse development.
5. Finally, we found that neurexins are equally important for
all LRRTM family proteins in mediating presynaptic differ-
entiation, at least in heterologous synapse-formation as-
says (Figure 7). Triple KD of neurexins completely abol-
ished the synaptogenic activity of LRRTM2 and LRRTM3
and partially decreased the synaptogenic activity of
LRRTM4, suggesting that neurexins are required for the
synaptogenic activity of all LRRTM proteins (Figures 7A
and 7B). In support of this interpretation, point mutants
of LRRTM2, -3, and -4 that are predicted to disrupt neu-
rexin-binding lacked synapse-inducing activity (Figures
7C, S8C, and S8D). However, different sets of presynaptic
neurexins are involved in LRRTM activities. For example,
LRRTM2 and LRRTM3 selectively formed complexes
with only #SS4-negative splice variants of neurexins,
whereas LRRTM4 induction of presynaptic differentiation
was linked to both #SS4-negative and positive splice var-
iants of neurexins (Figures 7D, 7E, and S7B; see de Wit
et al., 2013). Triple KD of hippocampal GPCs and KD of
PTPs also partially decreased the synaptogenic activity
of LRRTM4 (Figures 7A and 7B), consistent with a previous
report (Ko et al., 2015b). Collectively, these data indicate
that presynaptic neurexins are bona fide ligands for
LRRTMs and that GPCs act as additional ligands for
LRRTM4, although the functional significance of this latter
observation will require further investigation.
In summary, our data consistently support the conclusion that
LRRTM3 is critical for excitatory synapse development and func-
tion in hippocampal DG. The functional properties of LRRTM3
are similar to those of other LRRTMs in that LRRTM3 specifically
acts in promoting excitatory synapse development, maintains
surface AMPA receptor levels, and interacts with presynaptic
neurexins. In particular, various phenotypes of Lrrtm3-KO mice
are similar to those reported for Lrrtm4-KO mice (Siddiqui
et al., 2013). Intriguingly, both LRRTM3 and LRRTM4, together
with neurexins and GPCs, have been implicated in ASDs (Mi-
chaelson et al., 2012; Pinto et al., 2010), suggesting that these
molecular complexes contribute to ASD pathophysiology. In
keeping with this concept, our current results support the use(3*p < 0.001 and 2*p < 0.01, ANOVA with Tukey’s test; n denotes the total number
Control, n = 10; sh-Nrx1/2/3 (rescue + Nrx1b-1)/Control, n = 10; sh-Nrx1/2/3 (resc
sh-Nrx1/2/3 (rescue + Nrx1b-1)/L3S, n = 13; sh-Nrx1/2/3 (rescue + Nrx1b-3)/L3S,
Nrx1b-1)/L4S, n = 11; and sh-Nrx1/2/3 (rescue + Nrx1b-3)/L4S, n = 12. Scale ba
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to develop effective therapeutic avenues for ASDs.
EXPERIMENTAL PROCEDURES
Antibodies
LRRTM3[Long] peptide (JK092; CDLSTITSAGRISDHKPQLA) was synthesized
and conjugated to keyhole limpet hemocyanin through a cysteine added to the
N terminus of the peptide. Other antibodies were obtained commercially as
detailed in the Supplemental Experimental Procedures.
Production of Lentiviruses
Recombinant lentiviruses were produced by triply transfecting HEK293T cells
with three plasmids—various L-309 or L-313 vectors, psPAX, and pMD2G—
using FuGene-6 (Roche) as previously described (Ko et al., 2015b). Cultured
rat hippocampal neurons were infected at DIV3 and harvested at DIV12–13.
Knockdown efficacy was measured using qRT-PCR, as previously described
(Lee et al., 2013).
Cultured Neuron Preparation, Transfections, Imaging, and
Quantifications
Cultured hippocampal neurons were prepared from E18 rat brain, as previ-
ously described (Ko et al., 2006a, 2006b). For overexpression or KD of
LRRTM3 proteins in cultured neurons, hippocampal neurons were transfected
using a CalPhos Kit (Clontech) at DIV8–10 and immunostained at DIV14.
Electrophysiology
WT and Lrrtm3-KO mice (2 to 5 weeks old) were used in electrophysiological
experiments. The significance of differences between two groups was deter-
mined using Student’s t test or Mann-Whitney U test.
Heterologous Synapse-Formation Assays
HEK293T cells were transfected with pDisplay-LRRTM2 (HA-L2), pDisplay-
LRRTM3 (HA-L3L and HA-L3S), pDisplay-LRRTM4 (HA-L4L and HA-L4S), or
EGFP (Control) using FuGene (Roche). Heterologous synapse-formation as-
sayswere performed as previously described (Um et al., 2014a). For the exper-
iments presented in Figure 7, cultured hippocampal neurons were infected at
DIV3 with lentiviruses expressing shRNAs, as indicated, and incubated until
transfectedHEK293Tcellswere addedatDIV10 for synapse-formation assays.
Statistics
All data are expressed as mean ± SEM. All experiments were repeated with at
least three independent cultures and evaluated statistically using ANOVA with
post hoc Tukey’s test or Student’s t test.
Full experimental procedures and associated references are available in the
Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.12.081.
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